Skip to content
Screener

Werewolf Therapeutics, Inc. HOWL Q2 2026 earnings

Reported July 31, 2026 · Before market open

Revenue$21.0MIn line
EPS$0.08Beat by $0.36
Revenue estimate$21.0M
EPS estimate-$0.28

Next report

Nov 3, 2026 (in 3 months)
Revenue estimate$18.3M
EPS estimate-$0.22

FAQ

When did Werewolf Therapeutics, Inc. report Q2 2026 earnings?
Werewolf Therapeutics, Inc. (HOWL) reported Q2 2026 earnings on July 31, 2026 before market open.
What were Werewolf Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Werewolf Therapeutics, Inc. reported revenue of $21.0M and eps of $0.08 for Q2 2026.
Did Werewolf Therapeutics, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $21.0M by -. EPS beat the consensus estimate of $-0.28 by $0.36.
Where can I find Werewolf Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001785530-26-000018) and the 10-Q periodic report (0001785530-26-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.